发明名称 PROTEIN DISULFIDE ISOMERASE INHIBITING ANTICANCER AGENTS
摘要 Protein disulfide isomerase inhibitors according to formula I are described, wherein R1 is an aryl or cycloalkyl group, R2 is selected from the group consisting of CN, SO2CH3, NO2, CO2R3, CONHR3, NMe2, and CF3, R3 is selected from H or lower alkyl, R4 is H, halogen, CN, or COOH, and X and Y are C—H or heteroatoms selected from the group consisting of N, O, and S. The protein disulfide isomerase inhibitors can be used for the treatment of cancer in a subject.
申请公布号 EP3065739(A4) 申请公布日期 2017.03.22
申请号 EP20140860305 申请日期 2014.11.10
申请人 THE CLEVELAND CLINIC FOUNDATION 发明人 REU, Frederick J.;PHILLIPS, James;VATOLIN, Sergei;GRABOWSKI, Dale
分类号 C07D417/06;A61K31/427;A61P35/00;C07D495/04 主分类号 C07D417/06
代理机构 代理人
主权项
地址